Life sciences news
-
Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma
Friday August 23rd 2024
Read more
-
A potential new oral drug for leishmaniasis has successfully been tested in healthy humans
Thursday August 22nd 2024
Read more
-
AstriVax enters clinical phase with its novel vaccine platform technology
Monday June 24th 2024
Read more
-
Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024
Monday June 17th 2024
Read more
-
Strong data from Sequana Medical's DSR® proof-of-concept studies in heart failure published in European Journal of Heart Failure
Wednesday April 3rd 2024
Read more
-
Sequana Medical announces three month follow-up data from MOJAVE non-randomized cohort confirming dramatic improvement in diuretic response and virtual elimination of loop diuretics following DSR® therapy
Monday March 25th 2024
Read more
-
DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase
Wednesday February 28th 2024
Read more
-
Rejuvenate Biomed’s clinical trial demonstrates the therapeutic potential of RJx-01 in sarcopenia
Wednesday February 21st 2024
Read more
-
Become a flanders.bio member
Your news here?
-
Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure
Tuesday January 23rd 2024
Read more
-
KU Leuven researchers discover how to break the negative feedback loop to improve cancer immunotherapy
Tuesday January 16th 2024
Read more
-
Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients
Wednesday December 20th 2023
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
